Form 8-K - Current report:
SEC Accession No. 0001558370-18-002837
Filing Date
2018-04-09
Accepted
2018-04-09 08:19:33
Documents
3
Period of Report
2018-04-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 36080
2 EX-99.1 ex-99d1.htm EX-99.1 10763
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 15491
  Complete submission text file 0001558370-18-002837.txt   69615
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 18744583
SIC: 3841 Surgical & Medical Instruments & Apparatus